Open AccessHepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases
Author(s) -
C Fordy,
C Glover,
MM Davies,
TG Allen-Mersh
Publication year - 1998
Publication title -
british journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.833
H-Index - 236
eISSN - 1532-1827
pISSN - 0007-0920
DOI - 10.1038/bjc.1998.627
Subject(s) - floxuridine , fluorouracil , folinic acid , hepatic arterial infusion , medicine , gastroenterology , rectum , colorectal cancer , chemotherapy , cancer
Hepatic arterial floxuridine (HAI) in 35 patients with systemic fluorouracil/folinic acid-resistant colorectal liver metastases achieved a 14% partial response and 26% disease stabilization rate, with a median response duration of 7 months from onset of HAI.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom